Is there a generic for Aspirin; carisoprodol?

Yes. The FDA Orange Book lists 5 approved generic (ANDA) applications for Aspirin; carisoprodol, referencing the brand SOMA COMPOUND. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Aspirin; carisoprodol?

SOMA COMPOUND (NDA 012365, MEDA PHARMS) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Aspirin; carisoprodol are approved?

Aspirin; carisoprodol is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Aspirin; carisoprodol

Aspirin; carisoprodol is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:SOMA COMPOUND · NDA 012365

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
SOMA COMPOUND	MEDA PHARMS	NDA 012365	—	Jul 11, 1983

Generic (ANDA) products (5)

Product	Applicant	Application	TE	Approved
CARISOPRODOL AND ASPIRIN	INGENUS PHARMS LLC	ANDA 040832	—	Jan 07, 2010
CARISOPRODOL AND ASPIRIN	OXFORD PHARMS	ANDA 040252	—	Dec 10, 1997
CARISOPRODOL AND ASPIRIN	GENUS	ANDA 040116	—	Apr 25, 1996
CARISOPRODOL AND ASPIRIN	CHARTWELL RX	ANDA 089594	—	Mar 31, 1989
CARISOPRODOL COMPOUND	WATSON LABS	ANDA 088809	—	Oct 03, 1985

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Aspirin; carisoprodol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo